Your English writing platform
Discover LudwigExact(1)
The Subcutaneous Recombinant Interleukin-2 in Patients with HIV with Low CD4 Counts under Active Antiretroviral Therapy (SILCAAT) trial administered a dose of 4.5×10 IU twice daily for 5 days for six cycles with each cycle 8 weeks apart.
Similar(59)
All trials administered a total dose of 300 mg of doxycycline, spread over three days (Rahaman 1976 BGD), two days (De 1976 IND) or given as a single dose (Alam 1990 BGD).
All of these trials administered a different systemic antibiotic preoperatively for prophylaxis and evaluated the concentrations at different times during surgery and in different tissues (e.g., bone, subcutaneous tissue, blood).
The test sessions were conducted by one rotarod trial administered twice a week from 6 to 13 weeks.
The first-in-human trial administered QGE031 intravenously at a single site in the USA (January to December 2009), while the second trial administered QGE031 subcutaneously at three sites in the USA (May 2010 to September 2011).
Nontransgenic mice learned a new platform location each day during 4 consecutive acquisition trials, and exhibited memory for this location in a retention trial administered 30 min later.
The development of spatial memory for the platform location during the training sessions was evaluated in a probe trial administered 5 h after the last test on day 4.
This was a phase II, open-label, multicenter trial administered and monitored by SWOG.
The trial, administered in conjunction with the state government, was led by a US-based NGO, Path, which received millions of dollars from the Bill and Melinda Gates Foundation.
This was a phase II open label, multi-centre trial administered under the not for profit TORI network.
An "adverse event" is any untoward medical occurrence in a patient or clinical trial subject administered a medicinal product and which does not necessarily have a causal relationship with this treatment.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com